发明名称 RECOMBINANT HUMANIZED ANTI-FB5 ANTIBODIES
摘要 The invention provides for the production of several humanized murine antibodiesspecific for the antigen FB5, which is recognized by the murine antibody FB5. The FB5 antigen is expressed on the luminal surface of vascular endotholial cells of a wide range of malignant tumours. The invention also provides for numerous polynucleotide encoding humanized FB5 specific antibodies, expression vectors for producing humanized FB5 specific antibodies, and host cells for the recombinant production of the humanized antibodies. The invention also provides methods for detecting cancerous cells (in vitro and in vivo) using humanized FB5 specific antibodies. Additionally, the invention provides methods of treating cancer using FB5 specific antibodies.
申请公布号 CA2185116(A1) 申请公布日期 1995.09.14
申请号 CA19952185116 申请日期 1995.03.08
申请人 SCOTGEN BIOPHARMACEUTICALS, INC.;LUDWIG INSTITUTE FOR CANCER RESEARCH 发明人 WALLACE, THOMAS P.;CARR, FRANCIS J.;RETTIG, WOLFGANG J.;GARIN-CHESA, PILAR;OLD, LLOYD J.;HARRIS, WILLIAM J.
分类号 C07K16/30;C12N15/13;(IPC1-7):C12N15/13;A61K49/00;A61K51/10;C07K16/46 主分类号 C07K16/30
代理机构 代理人
主权项
地址